Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Clinical trial NCT00700882 · COMPLETED
Trial details
- NCT number
- NCT00700882
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-02
- Primary completion
- 2016-05-06
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.